Abstract
Human ether-á-go-go-related gene (hERG) K+ channel current (I hERG ) is inhibited by various compounds and genetic mutations, potentially resulting in cardiac arrhythmia. Here, we investigated effects of caffeic acid phenethyl ester (CAPE) and curcumin, two natural anti-inflammatory polyphenols, on I hERG in HEK-293 cells overexpressed with hERG. CAPE dose-dependently decreased repolarization tail current of hERG (I hERG,tail; IC50, 10.6 ± 0.5 μM). CAPE also shifted half-activation voltage (V 1/2) to the left (from −17.5 to −26.5 mV) and accelerated activation and inactivation kinetics. The CAPE inhibition of I hERG,tail was not attenuated in the pore-blocker site mutants of hERG (Y652A and F656A). A point mutation of Cys723 (C723S) mimicked the effects of CAPE and caused a left shift of V 1/2 and acceleration of I hERG,tail deactivation. However, I hERG,tail inhibition by CAPE was still observed in C723S. Taken together, CAPE inhibits hERG channel by class 3 mechanism, i.e., modification of gating, not by blocking the pore. Curcumin induced changes of I hERG similar to those of CAPE, while additional interaction with pore-blocking sites was suggested from attenuated I hERG,tail inhibition in Y652A and F656A. Interestingly, I hERG induced by human action potential voltage clamp was increased by CAPE while decreased by curcumin. Mathematical simulation of action potential derived from the experimental results of CAPE and curcumin supports that CAPE, but not curcumin, would induce shortening of AP duration by facilitation of I hERG . The above results revealed intriguing roles of Cys723 in hERG kinetics and suggested that conventional drug screening by using step pulse protocol for I hERG,tail would overlook the hERG kinetic modulations that could compensate the decrease of I hERG,tail.
Similar content being viewed by others
References
Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT (2006) Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113:365–373
Berube J, Caouette D, Daleau P (2001) Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J Pharmacol Exp Ther 297:96–102
Bogeski I, Kummerow C, Al-Ansary D, Schwarz EC, Koehler R, Kozai D, Takahashi N, Peinelt C, Griesemer D, Bozem M, Mori Y, Hoth M, Niemeyer BA (2010) Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci Signal 3:ra24
D’Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43:348–361
Delisle BP, Anson BD, Rajamani S, January CT (2004) Biology of cardiac arrhythmias: ion channel protein trafficking. Circ Res 94:1418–1428
Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H (1995) Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 26:185–192
Fernandez D, Ghanta A, Kauffman GW, Sanguinetti MC (2004) Physicochemical features of the HERG channel drug binding site. J Biol Chem 279:10120–10127
Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179–185
Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690–702
Fink M, Noble D, Virag L, Varro A, Giles WR (2008) Contributions of HERG K + current to repolarization of the human ventricular action potential. Prog Biophys Mol Biol 96:357–376
Fraga CG (2007) Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 59:308–315
Frolov RV, Ignatova II, Singh S (2011) Inhibition of HERG potassium channels by celecoxib and its mechanism. PLoS One 6:e26344
Gustina AS, Trudeau MC (2011) hERG potassium channel gating is mediated by N- and C-terminal region interactions. J Gen Physiol 137:315–325
Hu CW, Sheng Y, Zhang Q, Liu HB, Xie X, Ma WC, Huo R, Dong DL (2012) Curcumin inhibits hERG potassium channels in vitro. Toxicol Lett 208:192–196
Iost N, Virag L, Opincariu M, Szecsi J, Varro A, Papp JG (1998) Delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc Res 40:508–515
Kolbe K, Schonherr R, Gessner G, Sahoo N, Hoshi T, Heinemann SH (2010) Cysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels. J Physiol 588:2999–3009
Li J, Correa AM (2002) Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane. Anesthesiology 97:921–930
Mainardi T, Kapoor S, Bielory L (2009) Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123:283–294
Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59:2347–2352
Milnes JT, Witchel HJ, Leaney JL, Leishman DJ, Hancox JC (2010) Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: cisapride versus dofetilide. J Pharmacol Toxicol Methods 61:178–191
Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC (2000) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97:12329–12333
Mitcheson JS, Chen J, Sanguinetti MC (2000) Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J Gen Physiol 115:229–240
Nam JH, Shin DH, Zheng H, Kang JS, Kim WK, Kim SJ (2009) Inhibition of store-operated Ca2+ entry channels and K + channels by caffeic acid phenethylester in T lymphocytes. Eur J Pharmacol 612:153–160
Ono K, Ito H (1995) Role of rapidly activating delayed rectifier K + current in sinoatrial node pacemaker activity. Am J Physiol 269:H453–H462
Roden DM, Viswanathan PC (2005) Genetics of acquired long QT syndrome. J Clin Invest 115:2025–2032
Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R (2002) Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61:554–561
Shin DH, Seo EY, Pang B, Nam JH, Kim HS, Kim WK, Kim SJ (2011) Inhibition of Ca2+ −release-activated Ca2+ channel (CRAC) and K+ channels by curcumin in Jurkat-T cells. J Pharmacol Sci 115:144–154
Shin DH, Nam JH, Lee ES, Zhang Y, Kim SJ (2012) Inhibition of Ca2+ release-activated Ca2+ channel (CRAC) by curcumin and caffeic acid phenethyl ester (CAPE) via electrophilic addition to a cysteine residue of Orai1. Biochem Biophys Res Commun
Strimpakos AS, Sharma RA (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10:511–545
ten Tusscher KH, Noble D, Noble PJ, Panfilov AV (2004) A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 286:H1573–H1589
Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP (2012) hERG K(+) channels: structure, function, and clinical significance. Physiol Rev 92:1393–1478
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867–1876
Wilders R (2006) Dynamic clamp: a powerful tool in cardiac electrophysiology. J Physiol 576:349–359
Youm JB, Jo SH, Leem CH, Ho WK, Earm YE (2004) Role of stretch-activated channels in stretch-induced changes of electrical activity in rat atrial myocytes. Kor J Physiol Pharmacol 8:33–41
Acknowledgments
This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF 2011–0017370 and NRF 2012–0000809).
Author information
Authors and Affiliations
Corresponding authors
Appendix
Appendix
Current amplitude
Activation
For control:
For 10 μM CAPE:
For 10 μM curcumin:
Inactivation
First-order differential equations
Equilibrium potential of K+
Rights and permissions
About this article
Cite this article
Choi, S.W., Kim, K.S., Shin, D.H. et al. Class 3 inhibition of hERG K+ channel by caffeic acid phenethyl ester (CAPE) and curcumin. Pflugers Arch - Eur J Physiol 465, 1121–1134 (2013). https://doi.org/10.1007/s00424-013-1239-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-013-1239-7